Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancerGiacomo Bregni, Francesco Sclafani, Caroline Vandeputte et al.|Acta Oncologica|2021Cited by 11
Bevacizumab for recurrent glioblastoma, early observations on patient outcome in the belgian medical need programJohnny Duerinck, Anne Rogiers, Paul M. Clément et al.|Open Repository and Bibliography (University of Liège)|2012Cited by 1
Abstract CT250: A phase 1b / 2 study of JK06, a 5T4-targeted antibody drug conjugate, in patients with unresectable locally advanced or metastatic cancerOmar Saavedra, Nuria Kotecki, Maria deMiguel et al.|Cancer Research|2026Cited by 0
A phase 1b/2 study of JK06, a 5T4-targeted antibody-drug conjugate (ADC), in patients with unresectable locally advanced or metastatic cancer.Omar Saavedra, Nuria Kotecki, Fabricio Racca et al.|Journal of Clinical Oncology|2026Cited by 0